| 1 | 46,xy partial gonadal dysgenesis | Enrichment | GATA4, NR5A1, SOX9, SRY, WT1 | 16.00 |
| 2 | 46,xy complete gonadal dysgenesis | Enrichment | DHH, DMRT1, NR5A1, SOX9, SRY, WT1 | 16.00 |
| 3 | 46,xx sex reversal 1 | Enrichment | NR5A1, SOX9, SRY | 9.39 |
| 4 | Nonsyndromic 46,xx testicular disorders/differences of sex development | Enrichment | NR5A1, SOX9, SRY | 8.40 |
| 5 | 46,xy sex reversal 3 | Enrichment | GATA4, NR5A1 | 6.22 |
| 6 | 46,xy disorder of sex development | Enrichment | NR5A1, SRY | 5.05 |
| 7 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | Enrichment | DMRT1, GATA4, NR5A1 | 4.97 |
| 8 | Difference of sex development | Enrichment | NR5A1, WT1 | 4.78 |
| 9 | Persistent mullerian duct syndrome, types i and ii | Enrichment | AMH, AMHR2 | 4.75 |
| 10 | Persistent mullerian duct syndrome | Enrichment | AMH, AMHR2 | 4.75 |
| 11 | Tetralogy of fallot | Enrichment | GATA4, ZFPM2 | 3.72 |
| 12 | Male infertility | Enrichment | DMRT1, NR5A1 | 3.48 |
| 13 | Colorectal cancer | Enrichment | CTNNB1, FGFR2, SOX9 | 3.33 |
| 14 | 46,xy sex reversal 4 | Enrichment | DMRT1 | 3.09 |
| 15 | 46,xy sex reversal 7 | Enrichment | DHH | 3.09 |
| 16 | 46,xx sex reversal 4 | Enrichment | NR5A1 | 3.09 |
| 17 | Spermatogenic failure 8 | Enrichment | NR5A1 | 3.09 |
| 18 | Atrioventricular septal defect 4 | Enrichment | GATA4 | 3.09 |
| 19 | 46,xy sex reversal 10 | Enrichment | SOX9 | 3.09 |
| 20 | 46,xx sex reversal 2 | Enrichment | SOX9 | 3.09 |
| 21 | Meacham syndrome | Enrichment | WT1 | 3.09 |
| 22 | Atrial septal defect 2 | Enrichment | GATA4 | 3.09 |
| 23 | Multiple synostoses syndrome 3 | Enrichment | FGF9 | 3.09 |
| 24 | Testicular anomalies with or without congenital heart disease | Enrichment | GATA4 | 3.09 |
| 25 | Premature ovarian failure 7 | Enrichment | NR5A1 | 3.09 |
| 26 | 8p23.1 microdeletion syndrome | Enrichment | GATA4 | 3.09 |
| 27 | 45,x/46,xy mixed gonadal dysgenesis | Enrichment | SRY | 3.09 |
| 28 | Partial atrioventricular septal defect with ventricular hypoplasia | Enrichment | GATA4 | 3.09 |
| 29 | Blepharophimosis, ptosis, and epicanthus inversus | Enrichment | FOXL2 | 2.99 |
| 30 | Mullerian aplasia and hyperandrogenism | Enrichment | WNT4 | 2.99 |
| 31 | 46,xx sex reversal with dysgenesis of kidneys, adrenals, and lungs | Enrichment | WNT4 | 2.99 |
| 32 | Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and 46,xx sex reversal | Enrichment | RSPO1 | 2.99 |
| 33 | Palmoplantar keratoderma-xx sex reversal-predisposition to squamous cell carcinoma syndrome | Enrichment | RSPO1 | 2.99 |
| 34 | Campomelic dysplasia | Enrichment | SOX9 | 2.79 |
| 35 | Denys-drash syndrome | Enrichment | WT1 | 2.79 |
| 36 | Nephrotic syndrome, type 4 | Enrichment | WT1 | 2.79 |
| 37 | 46,xy gonadal dysgenesis with minifascicular neuropathy | Enrichment | DHH | 2.79 |
| 38 | Frasier syndrome | Enrichment | WT1 | 2.79 |
| 39 | 46,xy sex reversal 9 | Enrichment | ZFPM2 | 2.79 |
| 40 | 46,xy sex reversal 1 | Enrichment | SRY | 2.79 |
| 41 | Desmoplastic small round cell tumor | Enrichment | WT1 | 2.79 |
| 42 | Campomelic dysplasia and related disorders | Enrichment | SOX9 | 2.79 |
| 43 | Beare-stevenson cutis gyrata syndrome | Enrichment | FGFR2 | 2.75 |
| 44 | 46,xy sex reversal 5 | Enrichment | CBX2 | 2.75 |
| 45 | Scaphocephaly, maxillary retrusion, and impaired intellectual development | Enrichment | FGFR2 | 2.75 |
| 46 | Apert syndrome | Enrichment | FGFR2 | 2.75 |
| 47 | Bent bone dysplasia syndrome 1 | Enrichment | FGFR2 | 2.75 |
| 48 | Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay | Enrichment | PBX1 | 2.75 |
| 49 | Adenoid ameloblastoma | Enrichment | CTNNB1 | 2.75 |
| 50 | Non-syndromic unicoronal craniosynostosis | Enrichment | FGFR2 | 2.75 |
| 51 | Microcystic stromal tumor | Enrichment | CTNNB1 | 2.75 |
| 52 | Premature ovarian failure 3 | Enrichment | FOXL2 | 2.69 |
| 53 | Malignant granulosa cell tumor of the ovary | Enrichment | FOXL2 | 2.69 |
| 54 | Mesothelioma, malignant | Enrichment | WT1 | 2.61 |
| 55 | Diaphragmatic hernia 3 | Enrichment | ZFPM2 | 2.61 |
| 56 | Mullerian duct aplasia, unilateral renal agenesis, and cervicothoracic somite anomalies | Enrichment | WNT4 | 2.51 |
| 57 | Aniridia 1 | Enrichment | WT1 | 2.49 |
| 58 | Spermatogenic failure 1 | Enrichment | NR5A1 | 2.49 |
| 59 | Multiple synostoses syndrome | Enrichment | FGF9 | 2.49 |
| 60 | Transposition of the great arteries | Enrichment | GATA4 | 2.49 |
| 61 | Osteopathia striata with cranial sclerosis | Enrichment | CTNNB1 | 2.45 |
| 62 | Aural atresia, congenital | Enrichment | FGFR2 | 2.45 |
| 63 | Pfeiffer syndrome | Enrichment | FGFR2 | 2.45 |
| 64 | Jackson-weiss syndrome | Enrichment | FGFR2 | 2.45 |
| 65 | Antley-bixler syndrome without genital anomalies or disordered steroidogenesis | Enrichment | FGFR2 | 2.45 |
| 66 | Childhood hepatocellular carcinoma | Enrichment | CTNNB1 | 2.45 |
| 67 | Split hand-foot malformation | Enrichment | FGFR2 | 2.45 |
| 68 | Juvenile nasopharyngeal angiofibroma | Enrichment | CTNNB1 | 2.45 |
| 69 | B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3) | Enrichment | PBX1 | 2.45 |
| 70 | Autosomal dominant nonsyndromic deafness | Enrichment | FGFR2 | 2.45 |
| 71 | Congenital hypogonadotropic hypogonadism | Enrichment | EMX2 | 2.45 |
| 72 | Teratoma | Enrichment | CTNNB1 | 2.45 |
| 73 | Renal hypoplasia, bilateral | Enrichment | PBX1 | 2.45 |
| 74 | Leber congenital amaurosis 10 | Enrichment | WT1 | 2.39 |
| 75 | Ventricular septal defect 1 | Enrichment | GATA4 | 2.39 |
| 76 | Congenital heart defects, multiple types, 4 | Enrichment | GATA4 | 2.39 |
| 77 | Blepharophimosis | Enrichment | FOXL2 | 2.38 |
| 78 | Conotruncal heart malformations | Enrichment | ZFPM2 | 2.31 |
| 79 | Wilms tumor, aniridia, genitourinary anomalies, and impaired intellectual development syndrome | Enrichment | WT1 | 2.31 |
| 80 | Pierre robin syndrome | Enrichment | SOX9 | 2.31 |
| 81 | Wilms tumor 5 | Enrichment | WT1 | 2.31 |
| 82 | Double outlet right ventricle | Enrichment | ZFPM2 | 2.31 |
| 83 | Crouzon syndrome | Enrichment | FGFR2 | 2.28 |
| 84 | Desmoid disease, hereditary | Enrichment | CTNNB1 | 2.28 |
| 85 | Lacrimoauriculodentodigital syndrome 1 | Enrichment | FGFR2 | 2.28 |
| 86 | Neurodevelopmental disorder with spastic diplegia and visual defects | Enrichment | CTNNB1 | 2.28 |
| 87 | Anus, imperforate | Enrichment | CTNNB1 | 2.28 |
| 88 | Exudative vitreoretinopathy 7 | Enrichment | CTNNB1 | 2.28 |
| 89 | Desmoid tumor | Enrichment | CTNNB1 | 2.28 |
| 90 | Schizencephaly | Enrichment | EMX2 | 2.15 |
| 91 | Saethre-chotzen syndrome | Enrichment | FGFR2 | 2.15 |
| 92 | Pilomatrixoma | Enrichment | CTNNB1 | 2.15 |
| 93 | Alazami syndrome | Enrichment | CTNNB1 | 2.15 |
| 94 | Craniopharyngioma | Enrichment | CTNNB1 | 2.15 |
| 95 | Glioma | Enrichment | FGFR2 | 2.15 |
| 96 | Leukemia, acute lymphoblastic 3 | Enrichment | WT1 | 2.14 |
| 97 | Hemifacial hyperplasia | Enrichment | FGFR2 | 2.05 |
| 98 | Exudative vitreoretinopathy 1 | Enrichment | CTNNB1 | 2.05 |
| 99 | 46 xx gonadal dysgenesis | Enrichment | NR5A1 | 2.01 |
| 100 | Diaphragmatic hernia, congenital | Enrichment | ZFPM2 | 1.98 |
| 101 | Weyers acrofacial dysostosis | Enrichment | CTNNB1 | 1.98 |
| 102 | Split-hand/foot malformation 1 | Enrichment | FGFR2 | 1.98 |
| 103 | Adrenocortical carcinoma | Enrichment | CTNNB1 | 1.98 |
| 104 | Aortic aneurysm, familial thoracic 1 | Enrichment | GATA4 | 1.95 |
| 105 | Heart disease | Enrichment | GATA4 | 1.95 |
| 106 | Wilms tumor 1 | Enrichment | WT1 | 1.92 |
| 107 | Kidney disease | Enrichment | WT1 | 1.92 |
| 108 | Gallbladder cancer | Enrichment | CTNNB1 | 1.91 |
| 109 | Ovarian cancer | Enrichment | CTNNB1, WT1 | 1.87 |
| 110 | Exudative vitreoretinopathy | Enrichment | CTNNB1 | 1.85 |
| 111 | Cryptorchidism | Enrichment | INSL3 | 1.85 |
| 112 | Heart, malformation of | Enrichment | GATA4 | 1.84 |
| 113 | Patent foramen ovale | Enrichment | GATA4 | 1.84 |
| 114 | Cryptorchidism, unilateral or bilateral | Enrichment | INSL3 | 1.80 |
| 115 | Adult hepatocellular carcinoma | Enrichment | CTNNB1 | 1.80 |
| 116 | Focal segmental glomerulosclerosis | Enrichment | WT1 | 1.79 |
| 117 | Meier-gorlin syndrome 1 | Enrichment | FGFR2 | 1.76 |
| 118 | Familial atrial fibrillation | Enrichment | GATA4 | 1.71 |
| 119 | Medulloblastoma | Enrichment | CTNNB1 | 1.61 |
| 120 | Connective tissue disease | Enrichment | SOX9 | 1.59 |
| 121 | Hydrocephalus | Enrichment | FGFR2 | 1.58 |
| 122 | Genetic steroid-resistant nephrotic syndrome | Enrichment | WT1 | 1.56 |
| 123 | Polycystic liver disease | Enrichment | CTNNB1 | 1.53 |
| 124 | Autosomal dominant polycystic liver disease | Enrichment | CTNNB1 | 1.53 |
| 125 | Craniosynostosis | Enrichment | FGFR2 | 1.46 |
| 126 | Endometrial cancer | Enrichment | FGFR2 | 1.44 |
| 127 | Hepatoblastoma | Enrichment | CTNNB1 | 1.44 |
| 128 | Hepatocellular carcinoma | Enrichment | CTNNB1 | 1.42 |
| 129 | Primary ovarian insufficiency | Enrichment | WT1 | 1.33 |
| 130 | Bladder cancer | Enrichment | CTNNB1 | 1.30 |
| 131 | Gastric cancer | Enrichment | FGFR2 | 1.13 |
| 132 | Hypertelorism | Enrichment | FGFR2 | 1.05 |
| 133 | Inherited cancer-predisposing syndrome | Enrichment | WT1 | 0.99 |
| 134 | Congenital nervous system abnormality | Enrichment | CTNNB1 | 0.77 |
| 135 | Nervous system disease | Enrichment | CTNNB1 | 0.77 |
| 136 | Autism spectrum disorder | Enrichment | PBX1 | 0.75 |
| 137 | Microcephaly | Enrichment | CTNNB1 | 0.71 |